When to Administer Compazine (Prochlorperazine)
Prochlorperazine (Compazine) should primarily be administered for the control of severe nausea and vomiting, particularly in patients with cancer-related nausea, chemotherapy-induced nausea, or uncomplicated nausea and vomiting in emergency settings. 1
Primary Indications
Nausea and Vomiting Management
Cancer-related nausea: Prochlorperazine is effective for patients experiencing opioid-induced nausea or other causes of nausea in cancer patients. It should be considered as a first-line phenothiazine antiemetic option. 2
Chemotherapy-induced nausea: Recommended for low to moderate emetogenic potential chemotherapy (grade 1-2), typically at a dose of 10 mg orally every 6 hours as needed. 2
Emergency department treatment: Effective for rapid control of uncomplicated nausea and vomiting in emergency settings, with significantly better and faster symptom relief compared to alternatives like promethazine. 3
Post-operative nausea: Can be used to manage nausea and vomiting following surgical procedures, targeting dopaminergic pathways. 2
Dosing Guidelines
Oral Administration
- Standard dosing: 10 mg orally every 6 hours as needed 2
- Prophylactic use: May be given as pretreatment before chemotherapy with low emetogenic potential 2
Intravenous Administration
- Emergency setting: 2.5-10 mg IV (slow push over 1-2 minutes) 4, 5
- Repeat dosing: May repeat 2.5 mg after 20 minutes if no response to initial dose 4
Special Considerations
Combination Therapy
- For persistent nausea, particularly in cancer patients, consider combination therapy:
Cautions and Contraindications
Pregnancy: Not recommended during pregnancy except in cases of severe, intractable nausea and vomiting where potential benefits outweigh risks 1
Nursing mothers: Use with caution as phenothiazines are excreted in breast milk 1
Bone marrow depression: Avoid in patients with history of blood dyscrasias or hypersensitivity reactions to phenothiazines 1
Lithium therapy: Monitor closely for encephalopathic syndrome when used with lithium 1
Fall risk: May cause somnolence, postural hypotension, and motor instability leading to falls 1
Adverse Effects to Monitor
Akathisia: Occurs in approximately 44% of patients within 1 hour of IV administration. Monitor for restlessness, inability to sit still, and pacing. Consider diphenhydramine for treatment. 6, 7
Extrapyramidal symptoms: Watch for dystonic reactions, especially with higher doses or prolonged use 1
Sedation: Less sedating than promethazine but still may impair mental/physical abilities 3
Algorithm for Selection
First-line for uncomplicated nausea/vomiting: Consider prochlorperazine 10 mg PO or 2.5-5 mg IV 3
If patient has history of extrapyramidal symptoms: Consider ondansetron instead 7
If sedation is desirable: Promethazine may be preferred 7
For persistent nausea despite prochlorperazine:
For chemotherapy patients:
Common Pitfalls
Infusion rate: Administering IV prochlorperazine too quickly increases risk of akathisia. Give as slow IV push over 1-2 minutes. 7
Inadequate monitoring: Failure to monitor for extrapyramidal symptoms for up to 48 hours after administration 6
Inappropriate use in high-risk patients: Avoid in patients with Parkinson's disease or other movement disorders 6
Monotherapy for highly emetogenic chemotherapy: Prochlorperazine alone is insufficient for highly emetogenic chemotherapy regimens 2
Remember that while prochlorperazine is effective for nausea and vomiting, it should be used with caution in elderly patients and those with cardiovascular disease due to potential hypotensive effects. Always assess for other causes of nausea before initiating therapy. 2